M Perrotta
Papers
1
Total Citations
15
H-Index
1
About
Dr. M. Perrotta is a leading figure in gynecologic oncology, with a focused research portfolio dedicated to refining surgical approaches for early-stage cervical cancer. Her most influential work, the "23 Concerv" prospective trial (2019, 15 citations), represents a landmark contribution to the field. This study rigorously evaluated the safety and efficacy of conservative surgery—specifically, less radical hysterectomy or cone biopsy with lymph node assessment—for patients with low-risk, early-stage disease. By demonstrating that fertility-sparing and less morbid procedures can achieve excellent oncologic outcomes, Dr. Perrotta’s research has directly challenged traditional treatment paradigms, offering women a chance to preserve reproductive function without compromising survival. This work has been widely cited in clinical guidelines and has spurred further investigations into de-escalation of therapy. Beyond this pivotal trial, Dr. Perrotta’s broader research agenda encompasses patient-reported outcomes, surgical innovation, and the integration of molecular biomarkers to personalize treatment. Her contributions have not only advanced surgical practice but have also empowered patients through less invasive options, cementing her reputation as a compassionate and pioneering surgeon-scientist in the fight against cervical cancer.
Research Focus
Key Achievements
Top Papers
- 1